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Abstract
Background: Enterohemorrhagic Escherichia coli (EHEC) cause diarrhea-associated hemolytic uremic syndrome (D+ HUS)
worldwide, but no systematic study of EHEC as the causative agents of HUS was performed in the Czech Republic. We
analyzed stools of all patients with D+ HUS in the Czech Republic between 1998 and 2012 for evidence of EHEC infection.
We determined virulence profiles, phenotypes, antimicrobial susceptibilities and phylogeny of the EHEC isolates.
Methodology/Principal Findings: Virulence loci were identified using PCR, phenotypes and antimicrobial susceptibilities
were determined using standard procedures, and phylogeny was assessed using multilocus sequence typing. During the
15-year period, EHEC were isolated from stools of 39 (69.4%) of 56 patients. The strains belonged to serotypes [fliC types]
O157:H7/NM[fliCH7] (50% of which were sorbitol-fermenting; SF), O26:H11/NM[fliCH11], O55:NM[fliCH7], O111:NM[fliCH8],
O145:H28[fliCH28], O172:NM[fliCH25], and Orough:NM[fliCH25]. O26:H11/NM[fliCH11] was the most common serotype
associated with HUS (41% isolates). Five stx genotypes were identified, the most frequent being stx2a (71.1% isolates).
Most strains contained EHEC-hlyA encoding EHEC hemolysin, and a subset (all SF O157:NM and one O157:H7) harbored cdt-
V encoding cytolethal distending toxin. espPa encoding serine protease EspPa was found in EHEC O157:H7, O26:H11/NM,
and O145:H28, whereas O172:NM and Orough:NM strains contained espPc. All isolates contained eae encoding adhesin
intimin, which belonged to subtypes b (O26), c (O55, O145, O157), c2/h (O111), and e (O172, Orough). Loci encoding other
adhesins (efa1, lpfAO26, lpfAO157OI-141, lpfAO157OI-154, iha) were usually associated with particular serotypes. Phylogenetic
analysis demonstrated nine sequence types (STs) which correlated with serotypes. Of these, two STs (ST660 and ST1595)
were not found in HUS-associated EHEC before.
Conclusions/Significance: EHEC strains, including O157:H7 and non-O157:H7, are frequent causes of D+ HUS in the Czech
Republic. Identification of unusual EHEC serotypes/STs causing HUS calls for establishment of an European collection of
HUS-associated EHEC, enabling to study properties and evolution of these important pathogens.
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Introduction
Enterohemorrhagic Escherichia coli (EHEC) are the pathogenic
subgroup of Shiga toxin (Stx)-producing E. coli strains that cause
human diseases including diarrhea, bloody diarrhea and hemolytic
uremic syndrome (HUS). HUS is a severe, potentialy life-
threatening condition characterized by non-immune hemolytic
anemia, thrombocytopenia, and acute renal failure [1]. HUS
caused by EHEC strains is typically preceded with diarrhea (and
therefore designated D+ HUS), that usually begins as non-bloody
and progresses to bloody after several days [1]. D+ HUS usually
affects children under 5 years [1] and is the most common cause of
acute renal insufficiency in children. It develops in 10–15%
children infected with EHEC O157:H7 [1] and also complicates
infections with other EHEC serotypes [2–9]. In addition to the
kidneys, other organs can be affected during HUS including the
central nervous system, the pancreas, the heart, the liver and the
lungs [1]. The involvement of the central nervous system is the
most severe and is associated with higher mortality [6]. The
mortality of D+ HUS during the acute phase is ,5%, and there is
a high frequency of late renal or non-renal sequelae in survivors
[10,11].
Microvascular endothelial damage is the major pathological
change underlying HUS [1,12]. Stxs are presently the best
characterised EHEC virulence factors that cause the microvascu-
lar endothelial injury [12]. Stxs are released by EHEC in the
intestine, absorbed across the intestinal epithelium into the
circulation, and transported to microcapillaries of the target
organs, mainly the kidneys and the brain. Here Stxs bind to
glycosphingolipids of the globo-series, which are abundantly
expressed on both glomerular and brain microvascular endothelial
cells [13,14]. This triggers a complex cascade of events resulting in
a multi-organ thrombotic process [12]. Although the Stx family is
highly heterogeneous, not all Stx types have been associated with
HUS [15,16]. Stx2 is the most common Stx type found in EHEC
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isolated from HUS patients [3,15–17], but Stx2c, Stx2d and Stx1
also occur in HUS-associated EHEC [3,15]. In contrast, Stx2b,
Stx2e, Stx2f and Stx2g have not been found at all or are found
very rarely among HUS isolates [15,16,18–20]. A possible
explanation for the epidemiological association of Stx2 with severe
outcome of EHEC infections is the in vitro observation that Stx2 is
significantly more cytotoxic towards human renal [21] and human
brain [22] microvascular endothelial cells than Stx1.
The classical non-sorbitol-fermenting (NSF) EHEC O157:H7 is
the predominant cause of HUS worldwide [1,23,24]. In addition,
several other EHEC serotypes, the most frequent of which are
O26:H11/NM (non-motile), O91:H21, O103:H2/NM,
O111:H8/NM, O113:H21, and O145:H25/H28/NM, have been
increasingly recognized as causes of HUS in Europe [3–5,7,17,25–
27], North America [8], South America [20], and Australia [28].
EHEC strains that have the capability of causing HUS have been
designated HUSEC (HUS-associated E. coli) [3].
The role of EHEC as causes of HUS in the Czech Republic has
not yet been systematically studied. Here, we investigated stool
samples from all patients with D+ HUS hospitalized in pediatric
centers in the Czech Republic between 1998 and 2012 for EHEC
infection. We determined serotypes of the EHEC isolates, a subset
of molecular and phenotypic characteristics, and their phyloge-
netic relationships. Moreover, we determined susceptibilities of the
strains to a spectrum of antimicrobials.
Materials and Methods
Ethics Statement
This study was approved by the Ethical Committee of the
University Hospital Motol, Prague, Czech Republic. Written
informed consent for enrollment in the study and publication of
patients data was obtained from parents of all patients.
Patients and Stool Samples
During January 1998 to December 2012, stool samples from 56
patients with HUS were investigated for EHEC infection in the
Reference Laboratory for E. coli and Shigella of the National
Institute of Public Health in Prague, Czech Republic. This
laboratory is specialized for diagnosis of EHEC infections and
receives stools from all patients with HUS from this country. The
patients originated from different regions of the Czech Republic
and there were no apparent temporal or geographical linkages
between them. Thirty-four of 56 patients (60.7%) were boys and
22 (39.3%) were girls. All patients were children (median age, 27.5
months; range, 10 to 85 months). Stool samples were collected
between 2 and 15 days (median, 6 days) after the onset of
prodromal diarrhea.
Case Definition
HUS was defined as a case of microangiopathic hemolytic
anemia (hematocrit ,30% with peripheral evidence of intravas-
cular hemolysis), thrombocytopenia (platelet count ,150,000
platelets/mm3), and renal insufficiency (serum creatinine concen-
tration higher than the upper limit of the normal range for age)
[1].
Detection of EHEC in and Isolation from Patients Stools
The stool samples were enriched in G.N. Enrichment Broth
(Hajna) (Laboratorios Conda, Madrid, Spain) with novobiocin
supplement (Oxoid, Hampshire, UK) for 5–7 hours (37uC,
180 rpm) and the enriched cultures were inoculated on Columbia
blood agar, sorbitol MacConkey agar (SMAC), cefixime-tellurite
(CT)-SMAC agar and enterohemolysin agar (all from Oxoid).
Since 2008, the enrichment cultures were additionally examined
for the presence of E. coli O157, O26, O103, O111, and O145
using an immunomagnetic separation (Dynabeads anti-E. coli
O157, Dynabeads EPEC/VTEC O26, Dynabeads EPEC/VTEC
O103, Dynabeads EPEC/VTEC O111, Dynabeads EPEC/
VTEC O145) according to the manufacturers (Dynal, Oslo,
Norway) protocol and subsequently plated on the above media.
After overnight incubation at 37uC, bacterial growth from all four
plates was collected in a tube containing 1ml of 0.85% NaCl;
100 ml of this suspension was dilluted 1:10 in sterile distilled water,
heated for 10 min at 100uC and centrifuged (12000 rpm, 10 min).
Supernatant was used as a template for PCR with primers KS7-
KS8, LP43-LP44, and SK1-SK2 which target stx1a, stx2a and eae,
respectively [3,15]. All stx-positive samples were further PCR
tested for genes of O antigen biosynthetic clusters of E. coli O157,
O26, O55, O111, O103, O145, O91 and O113 [29–31]. To
isolate strains from samples with positive stx PCR results, bacterial
suspensions were restreaked on SMAC, CT-SMAC and enter-
ohemolysin agar plates. E. coli O157:H7 was isolated from SMAC
and/or CT-SMAC using agglutination of sorbitol-negative colo-
nies in O157 antiserum (Denka Seiken Ltd., Tokyo, Japan).
EHEC of the major non-O157 serogroups (O26, O111, O145)
were isolated from enterohemolysin agar based on their typical
enterohemolytic phenotype combined with agglutination in
antisera against the respective E. coli O antigens (Sifin, Berlin,
Germany; Denka Seiken). If no sorbitol-negative or enterohemo-
lytic colonies were present on SMAC/CT-SMAC or enterohe-
molysin agar, respectively, multiple colonies from these plates
(altogether up to 50) were tested for stx1a and stx2a genes using
PCRs described above. The isolates were confirmed as E. coli
biochemically (API 20E; bioMérieux, Marcy l’Etoile, France) and
using a MALDI-TOF mass spectrometer (Microflex LT, Bruker
Daltonics, Germany). Mass spectra were processed using the
BioTyper software with the version 3.2.1.0. database. Motility of
the isolates was determined directly after isolation as follows: The
strains were inoculated into the middle of tubes containing soft
(0.5%) agar, incubated at 37uC and observed for growth daily. An
isolate was considered motile if it spread out of the original
inoculation site during 10 days. If there was no growth from the
inoculation site during this time, the isolate was considered
nonmotile (NM).
Detection of other Enteric Bacterial Pathogens in Stools
The presence of Salmonella spp., Shigella spp., Yersinia enterocolitica,
and Campylobacter jejuni in stools was sought using standard
microbiological procedures.
Serotyping
stx positive colonies were serotyped using agglutination in
polyvalent and monovalent E. coli O antisera (Denka Seiken Co.,
Ltd., Tokyo, Japan; Sifin, Berlin, Germany; Robert Koch
Institute, Wernigerode, Germany) and H antisera (Denka Seiken).
The presence of the O26, O55, O111, O145, O157, and O172
antigens was confirmed using PCRs targeting genes of the
respective O antigen biosynthetic clusters [29–32]. The flagellin
subunit–encoding fliC gene was subtyped using HhaI restriction
fragment length polymorphism as described previously [7].
Genotypic Characteristics
PCRs were performed in a MyCycler Thermal Cycler (Bio-
Rad, München, Germany) using reagents from Top-Bio (Prague,
Czech Republic) and primers from Generi Biotech (Hradec
Kralove, Czech Republic). All isolates were tested for stx1a, stx2a,
and their subtypes (stx1c, stx2b, stx2c, stx2d stx2e, stx2f) using published
HUS-Associated EHEC in the Czech Republic
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PCR protocols [15,16]. Genes encoding other toxins (cdt-V,
EHEC-hlyA, a-hlyA), the EHEC serine protease EspP (espP), and
adhesins (eae, efa1, lpfAO26, lpfAO157OI-141, lpfAO157OI-154, iha) were
PCR detected as described previously [15,33–38]. eae genes were
subtyped according to Zhang et al. [39] (eae b, c, e) and Blanco
et al. [40] (eae c2/h). espP genes were subtyped according to
Brockmeyer et al. [36]. terE and ureD used as markers for the ter
and ure gene clusters, which encode tellurite resistance urease
production, respectively, were amplified as described previously
[41,42]. Genes within the O island (OI) 122 of EHEC O157:H7
strain EDL933 (efa1, sen, nleE, nleB, pagC) were detected using
published PCR protocols [25,43].
Phenotypic Characteristics
Utilization of sorbitol was tested on SMAC. Moreover,
utilization of sorbitol, rhamnose and production of lysine
decarboxylase (LDC) was evaluated according to the API 20E
test kit (bioMérieux). Production of b-D-glucuronidase was
investigated using COLItest (Erba Lachema, Brno, Czech
Republic). Production of EHEC hemolysin and a hemolysin was
sought using enterohemolysin agar and Columbia blood agar
(Oxoid), respectively. Production of Stx was tested using a Vero
cell cytotoxicity assay [2]. The Stx titer was defined as the highest
dilution of culture supernatant that caused cytotoxicity in 50%
cells after 3 days of incubation. The Stx types (Stx1, Stx2) were
identified using VTEC-RPLA assay (Denka Seiken) according to
the manufacturer’s instructions. Resistance to tellurite was
determined based on the ability of the strains to grow on CT-
SMAC. Urease production was determined using the API 20E
test.
Antimicrobial Susceptibility Testing
Susceptibility to ampicillin, cefotaxime, ceftazidime, gentami-
cin, trimethoprim/sulfamethoxazole, ciprofloxacin, amikacin,
meropenem, piperacillin/tazobactam, tigecycline, chlorampheni-
col, and nitrofurantoin was tested using the disk diffusion method
according to EUCAST breakpoints [44] and standard recom-
mendations [45].
Multilocus Sequence Typing (MLST)
MLST was performed by sequencing internal fragments of
seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, and recA)
as described previously [3]. Sequences were analyzed and the
minimum-spanning tree was constructed using the SeqSphere
software version 0.9 beta.1 (Ridom GmbH, Münster, Germany).
All alleles and sequence types (ST) were assigned in accordance
with the MLST website (http://mlst.ucc.ie/mlst/dbs/Ecoli).
Results
Clinical Features
Among the 56 patients investigated, 52 (92.9%) had prodromal
diarrhea, which was bloody in 31 (59.6%). HUS was diagnosed
between 2 and 15 days (median, 6 days) after the onset of diarrhea.
The median length of hospitalization was 17 days (range, 4 to 55
days). Three patients (5.4%) died during acute phase of HUS. The
causes of the deaths were neurological complications (cerebral
edema) in two patients (girls, 18 and 25 months old, both infected
with EHEC O26:H11), one of whom also developed lung edema;
one patient (boy, 30 months old, infected with sorbitol-fermenting
(SF) EHEC O157:NM) died of acute renal failure. Deaths
occurred between 3 and 6 days (median, 3 days) after HUS
development.
Serotypes and fliC Genotypes of EHEC Isolates
Stool samples from 39 of 56 patients (69.6%) were positive in
screening for stx1a and/or stx2a genes using PCR. EHEC strains
were isolated from all of these 39 stx-positive stool samples. Thirty-
seven isolates belonged to eight different serotypes and two were
non-typeable (Orough) (Table 1). The most common serotype was
O26:H11/NM (non-motile), which accounted for 16 (41%) of 39
isolates (Table 1). The second most common serotype was
O111:NM (six of 39 isolates; 15.4%). NSF EHEC O157:H7/
NM were isolated from five (12.8%) patients and an additional five
patients (12.8%) were positive for SF EHEC O157:NM strains
(Table 1). One isolate belonged to serotype O172:NM, which has
been rarely isolated from patients with HUS [25].
Seven of 10 O157 isolates (two NSF and all five SF), six of 16
(37.5%) O26 isolates, and all O111, O55, O172 and Orough
isolates were non-motile, making conventional H typing impossi-
ble (Table 1). Subtyping of fliC genes encoding the flagellar subunit
of the H antigens demonstrated that the non-motile O157 and
O26 isolates contained fliCH7 and fliCH11, respectively, which was
also present in motile isolates of these serotypes. The non-motile
isolates of serogroups O111, O55 and O172 contained fliCH8,
fliCH7, and fliCH25, respectively (Table 1), allowing rapid molecular
H typing. fliCH25 was also present in both Orough:NM isolates
(Table 1).
None of the 39 patients from whom EHEC strains were isolated
had other intestinal bacterial pathogens (Salmonella spp., Shigella
spp., Y. enterocolitica, C. jejuni) in their stools.
Seasonal Distribution of EHEC Serotypes
Most EHEC strains (29 of 39; 74.4%) were isolated during the
warm period of the year (May to September) (Figure 1). However,
no clear seasonality in occurrence of particular serotypes was
observed. NSF O157:H7/NM strains were isolated from January
through August and SF O157:NM from February to June.
O26:H11/NM isolates were almost equally distributed throughout
the year (Figure 1).
stx Genotypes
stx genes were present in all 39 EHEC isolates upon isolation,
but one strain (SF O157:NM) lost its stx gene during laboratory
subcultures before stx subtyping could be performed. Three
different stx alleles (stx1a, stx2a, stx2c), which through different
combinations gave rise to five stx genotypes, were identified among
the remaining 38 strains (Table 1). The stx2a genotype was the
most frequent, being present in 27 of 38 (71.1%) strains. The stx2a
genotype was identified in all strains of serotypes O157:NM (SF),
O55:NM, O145:H28, O172:NM, Orough:NM, and in the
majority (15 of 16) of O26:H11 strains (Table 1). Only one of
five NSF EHEC O157 isolates contained the stx2a as the only stx
gene. The other four NSF O157 strains harbored stx2c in
combination with either stx1a or stx2a gene. stx2c did not occur in
any other serotype (Table 1). stx1a as the only stx gene was found in
three of 38 strains (7.9%) including one of 16 EHEC O26:H11
and two of six O111:NM strains (Table 1).
Non-stx Virulence Genes
Strains of all but one serotype (O55:NM) contained genes
encoding non-Stx toxins including cytolethal distending toxin V
(Cdt-V) and/or EHEC hemolysin (Table 1). Both cdt-V and
EHEC-hlyA genes were present in four of five SF O157:NM strains
and in one NSF O157:H7 strain (Table 1). EHEC-hlyA, but not
cdt-V, was present in all strains of serotypes O26:H11/NM,
O145:H28, O172:NM, and Orough:NM, and in four NSF
HUS-Associated EHEC in the Czech Republic
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O157:H7/NM and four O111:NM isolates (Table 1). None of the
39 strains contained a-hlyA gene encoding a hemolysin (Table 1).
All or most strains of serotypes O157:H7/NM (NSF), O26:H11/
NM, O145:H28, O172:NM and Orough:NM contained the espP
gene encoding the plasmid-encoded serine protease EspP [36].
Subtyping of the espP genes demonstrated that the O157:H7/NM,
O26:H11/NM and O145:H28 strains contain espPa, whereas the
O172:NM and Orough:NM strains contain espPc; each of these
espP alleles encodes proteolytically active EspP [36]. espP was
absent from all strains of serotypes O157:NM (SF), O55:NM, and
O111:NM (Table 1).
All 39 EHEC isolates contained the eae gene encoding intimin,
the major adhesin of EHEC. Four different eae subtypes (ß, c, c2/
h, e) were identified, which were associated with particular
serotypes. The eae c allele was broadly distributed (being present in
all O157, O55, and O145 strains), whereas the other eae alleles (ß,
c2/h, e) were usually restricted to one serotype (Table 1). In
addition to eae, genes encoding other established or putative
adhesins were found in the EHEC isolates. The efa1 gene encoding
the EHEC factor for adherence (Efa-1) [34] was present in strains
of all serotypes (Table 1), but it was truncated in NSF O157:H7/
NM and in one of O145:H28 strains as reported previously for E.
coli O157:H7 [34]. In contrast, loci encoding other adhesins
(lpfAO26, lpfAO157OI-141, lpfAO157OI-154, iha) were restricted to only
some serotypes (Table 1).
Other Loci
All NSF O157:H7/NM, O26:H11/NM, and O145:H28
strains, and five of six O111:NM strains contained terE and ureD
genes, which were used as markers for the gene clusters encoding
tellurite resistance and urease production, respectively. These loci
were found in none of the strains of the other serotypes (Table 1).
The irp2 and fyuA genes, which are components of the iron-uptake
system encoded in the high pathogenicity island (HPI) identified in
EHEC by Karch et al. [46] were present only in strains of serotype
O26:H11/NM (Table 1).
Table 1. Serotypes and genotypic characteristics of EHEC strains isolated from patients with HUS in the Czech Republic, 1998–
2012.





(SF) O55:NM O26:H11/NM O111:NM O145:H28 O172:NM Orough:NM
fliCH7 (n = 5) fliCH7 (n = 5) fliCH7 (n = 2) fliCH11 (n = 16) fliCH8 (n = 6) fliCH28 (n = 2) fliCH25 (n = 1) fliCH25 (n = 2)
stx1a 2
c – – + (1)c + (2) – – –
stx2a + (1) + (4)d + + (15) – + + +
stx1a+stx2a – – – – + (4) – – –
stx1a+stx2c + (2) – – – – – – –
stx2a+stx2c + (2) – – – – – – –
cdt–V + (1) + – – – – – –
EHEC–hlyA + + (4) – + + (4) + + +
a–hlyA – – – – – – – –
espPe + (a) – – + (a) (9) – + (a) (1) + (c) + (c)
eaef + (c) + (c) + (c) + (ß) + (c2/h) + (c) + (e) + (e)
efa1 +g + + + + +g + +
lpfAO26 – – – + + – – –
lpfAO157/OI–141 + + + – – + – –
lpfAO157/OI–154 + + + – – – – –
iha + – – + + (5) + – –
terE + – – + + (5) + – –
ureD + – – + + (5) + – –
irp2 – – – + – – – –
fyuA – – – + – – – –
aThe genes encode the following proteins: fliC, flagellar subunit of H antigen; stx, Shiga toxin; cdt-V, cytolethal distending toxin V; EHEC-hlyA, EHEC hemolysin; a-hlyA,
a hemolysin; espP, serine protease EspP; eae, intimin; efa1, EHEC factor for adherence; lpfAO26, major subunit of long polar fimbriae of EHEC O26; lpfA O157/OI-141 and
lpfAO157/OI-154, major subunit of long polar fimbriae of EHEC O157 encoded on O island OI 154 and OI 141, respectively; iha, iron-regulated gene A homologue adhesin;
terE, marker for tellurite resistence-encoding cluster; ureD, marker for ure cluster encoding urease production; irp2 and fyuA, markers for the high pathogenicity island
(HPI) encoding iron uptake system.
bSerotypes were determined using conventional and molecular serotyping; the fliC genes indicated were present in both motile and non-motile strains of each
respective serotype; NSF, non-sorbitol-fermenting; SF, sorbitol-fermenting.
c2, the gene was absent; +, the gene was present (if the gene was not present in all strains of the respective serotype, the numbers of positive strains are indicated in
parenthesis).
done strain lost stx gene before subtyping.
eespP subtypes are indicated in parentheses.
feae subtypes are indicated in parentheses.
ga truncated efa1 gene [34] was present in EHEC O157:H7 and one O145:H28 isolate; complete efa1 was present in all other strains.
doi:10.1371/journal.pone.0073927.t001
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Presence of OI 122 in EHEC Isolates
The presence of OI 122 in EHEC strains, and the gene content
of this genomic island (i.e. the presence of pagC, nleE, nleB, sen, and
efa1 loci) correlate with virulence of EHEC strains [25,43]. In
accordance with their origin from patients with HUS, the EHEC
strains characterized in this study contained a complete OI 122
(serotypes O157:H7/NM, O55:NM, O111:NM, and one
O145:H28 strain) or an incomplete OI 122 which lacked only
pagC (serotypes O26:H11, O172:NM, Orough:NM, and one
O145:H28 strain) (Table 2).
Phenotypes
All but one strain (SF O157 which lost stx gene) expressed Stx as
demonstrated by cytotoxicity of their culture supernatants to Vero
cells (Table 1). The Stx type produced by each strain determined
using a latex agglutination assay correlated with stx genotype.
Specifically, strains harboring stx1a only produced Stx1a only,
those harboring stx2a only produced Stx2a only, and those
harboring stx1a+stx2a produced both Stx1a and Stx2a (Table 1,
Table 3). Stx2c produced by O157:H7 strains with stx genotypes
stx1a+stx2c or stx2a+stx2c was detected using the Stx2 latex reagent
(Table 3). EHEC hemolysin was expressed by all EHEC-hlyA-
harboring strains of serotypes O157:H7/NM (NSF), O111:NM,
O145:H28, and by 15 of 16 EHEC-hlyA-containing O26:H11/
NM. No EHEC hemolysin production was observed in EHEC-
hlyA-positive SF EHEC O157:NM strains or in strains of serotypes
O172:NM and Orough:NM (Table 3). In accordance with the
absence of a-hlyA gene (Table 1), none of the 39 EHEC isolates
produced a hemolytic phenotype on blood agar (Table 3) Tellurite
resistance was expressed in all strains of serotypes O157:H7/NM
(NSF), O26:H11/NM, O111:NM, and O145:H28 which con-
tained the terE gene, as demonstrated by their ability to grow on
CT-SMAC. In contrast, none of the above strains, which also
contained ureD, produced urease (Table 3). Sorbitol was utilized by
all strains except for NSF O157:H7/NM, O172:NM, and
Orough:NM as demonstrated by the appearance of their colonies
Figure 1. Seasonal distribution of EHEC strains of different serotypes isolated from patients with HUS in the Czech Republic, 1998–
2012.
doi:10.1371/journal.pone.0073927.g001
Table 2. Presence of OI 122 among EHEC isolates from HUS patients.
Locus of
OI 122 Serotype (number of strains)
O157:H7/NM
(NSF) O157:NM (SF) O55:NM O26:H11/NM O111:NM O145:H28 O172:NM Orough:NM
fliCH7 (n = 5) fliCH7 (n = 5) fliCH7 (n = 2) fliCH11 (n = 16) fliCH8 (n = 6) fliCH28 (n = 2) fliCH25 (n = 2) fliCH25 (n = 1)
pagC + + + – + + (1)a – –
nleE + + + + + + + +
nleB + + + + + + + +
sen + + + + + + + +
efa1 + + + + + + + +
OI-122b C C C I C C (1)
I (1)
I I
apagC was present in one strain.
bC, complete OI 122 (all genes tested present); I, incomplete OI 122 (pagC absent).
doi:10.1371/journal.pone.0073927.t002
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on SMAC and using API 20E test. Rhamnose was utilized by all
NSF O157:H7/NM, O111:NM, and O145:H28 strains, but not
by strains of the other serotypes (Table 3). All strains except those
belonging to serotypes O111:NM, O172:NM and Orough:NM
produced lysine decarboxylase (Table 3). All strains but NSF
O157:H7/NM produced ß-D-glucuronidase (Table 3).
Antimicrobial Susceptibility
Nine of 39 EHEC isolates including five of 16 O26:H11/NM
strains, and four of six O111:NM strains were resistant to
ampicillin. One of these O26 isolates was also resistant to
trimethoprim/sulfamethoxazole. One additional isolate
(O145:H28) was resistant to chloramphenicol. All the other 29
strains including all 10 O157 isolates were susceptible to all 12
antimicrobials tested (ampicillin, cefotaxime, ceftazidime, genta-
micin, trimethoprim/sulfamethoxazole, ciprofloxacin, amikacin,
meropenem, piperacillin/tazobactam, tigecycline, chlorampheni-
col, and nitrofurantoin).
Phylogeny of EHEC Associated with HUS
MLST analysis of the 39 EHEC isolates resulted in nine
different STs. Whereas eight of the nine STs clustered into three
CCs (CC11, CC29, CC32), ST660 formed a separate clone not
clustering into any known CC (Table 4). All EHEC O157:H7/
NM (NSF) and O157:NM (SF) belonged, with a single exception
(ST1595, which is a single locus variant (slv) of ST11) to ST11
(CC11). Both O55:NM strains (ST335) grouped as a slv of ST11
into the same CC (CC11) as EHEC O157:H7/NM. EHEC
O26:H11/NM were equally distributed among two different STs,
ST21 and ST29, which clustered together into CC29. The ST29 is
composed of strains belonging to the new, highly virulent EHEC
O26 clone, which is widespread in Europe [7]. All six strains of
serotype O111:NM belonged to ST16 (a slv of ST29) and grouped
to CC29 together with EHEC O26 (Table 4). Both O145:H28
strains clustered into CC32 and belonged to ST32 and ST137,
respectively, which are slvs. The O172:NM strain and both
Orough:NM strains belonged to ST660, suggesting that they have
a similar genomic background. Accordingly, a PCR analysis for
the presence of the O172 biosynthetic cluster gave a positive result
in all three strains demonstrating that they are all genetically
O172. Phylogenetic relationships of the Czech HUS-associated
strains, the distribution of strains of different serotypes into CCs
and the comparison to the HUSEC collection [3] (www.ehec.org)
are shown in Figure 2. Interestingly, this comparison revealed the
presence of two STs that were not associated with HUS
previously, namely ST660 and ST1595.
Discussion
In this 15-year study we systematically investigated stools of
patients with HUS for the evidence of EHEC infection. We
demonstrate that approximately 70% of patients with D+ HUS
contained EHEC strains in their stool samples. Similar to other
European countries, EHEC associated with HUS in the Czech
Republic involved strains of serogroup O157 and also several non-
O157 serogroups. Notably, SF EHEC O157:NM, which were first
identified in Germany [47] and later in other European countries
[25,48–51], accounted for 50% of all EHEC O157 strains isolated
from HUS patients in the Czech Republic during 1998–2012. All
SF O157:NM isolates from the Czech Republic possessed stx2a
gene, similar to such strains from Germany, but not stx1a which
was identified in SF O157:NM isolated in Norway [50]. The most
prevalent EHEC serotype associated with HUS in the Czech
Table 3. Phenotypes of EHEC strains isolated from patients with HUS in the Czech Republic.
Phenotypea Serotype (number of strains)
O157:H7/NM (NSF) O157:NM (SF) O55:NM O26:H11/NM O111:NM O145:H28 O172:NM Orough:NM
fliCH7 (n = 5) fliCH7 (n = 5) fliCH7 (n = 2) fliCH11 (n = 16) fliCH8 (n = 6) fliCH28 (n = 2) fliCH25 (n = 1) fliCH25 (n = 2)
Vero cell titerb 32–128 16–512 32–64 16–128 64–2048 256–1024 128 512
Stx 1c –d – – + (1)d + (2) – – –
Stx 2c + (3) + (4) + + (15) – + + +
Stx1+Stx2c + (2) – – – + (4) – – –
EHEC–Hly + – – + (15)e + (4) + –e –e
a–Hly – – – – – – – –
CT–SMAC growth + – – + + (5) + – –
Urease – – – – – – – –
SMAC – + + + + + – –
SOR – + + + + + – –
RHA + – – – + + – –
LDC + + + + – + – –
GLR – + + + + + + +
aEHEC-Hly, EHEC hemolysin production; a-Hly, a hemolysin production; growth on CT-SMAC, indicator of tellurite resistance; urease, urease production; SMAC,
utilization of sorbitol on sorbitol MacConkey agar; SOR, utilization of sorbitol (API 20E); RHA, utilization of rhamnose (API 20E); LDC, production of lysine decarboxylase;
GLR, production of ß-D-glucuronidase.
bThe highest dilution of culture supernatant which caused cytotoxicity in 50% Vero cells after 3 days.
cProduction of Stx1 and Stx2 tested using the VTEC - RPLA kit.
d2, the phenotype was absent; +, the phenotype was present (the numbers in parentheses indicated numbers of positive strains in the case that not all strains
expressed the respective phenotype).
eone O26:H11 and O172:NM and Orough:NM strains did not express EHEC-hlyA gene.
doi:10.1371/journal.pone.0073927.t003
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Republic is O26:H11/NM, a situation similar to that reported
from Italy [26]. Our ability to isolate EHEC strains from all stool
samples that tested positive for stx genes in the initial PCR
screening demonstrates that the EHEC isolation procedure used in
this study enables to identify reliably both O157 and non-O157
EHEC strains. In accordance with other studies [3,37,49], the
large percentage of the Czech EHEC isolates were non-motile.
This suggests that non-motility might either be an inherent
characteristic of EHEC, in particular of some serogroups, or that
such strains rapidly lose their motility in vitro, after they have left
the host gastrointestinal tract. This observation underlines the
importance of the fliC genotyping as an easy, rapid and reliable
procedure for molecular H typing of EHEC isolates.
All EHEC isolated from HUS patients in the Czech Republic
were eae-positive as are also most HUS-associated EHEC in other
studies [5,8,15,17]. It has been shown in different studies that the
rate of eae-negative strains among HUS EHEC isolates is low
[3,17,28]. Mellmann et al. [3] reported that only 16 from 524
(3.1%) EHEC isolates from HUS patients were eae-negative.
Among them was E. coli O104:H4 strain (HUSEC41) [3], which is
closely related to the E. coli O104:H4 strain that caused the largest
ever recorded outbreak of HUS in Germany in 2011 [52,53], with
many secondary cases having occurred worldwide including the
Czech Republic [54]. The O104:H4 outbreak strain isolated in
2011 from an American tourist with diarrhea who traveled to
Prague from North Germany [54] is the only eae-negative EHEC
isolated in this country from humans until now. Because stx-
positive/eae-negative strains would have been detected using our
PCR screening system, we assume that the absence of eae-negative
strains among EHEC isolated from HUS patients in the Czech
Republic in this study is due to low number of isolates resulting, in
Figure 2. Phylogeny of EHEC associated with HUS in the Czech Republic. Minimum-spanning tree illustrating the clonal relationship
between HUS-associated EHEC from the Czech Republic (green) and the HUSEC collection [3] (red) based on MLST allelic profiles. Each MLST
sequence type (ST) is represented by a node named with its ST. The size of the node is proportional to the number of isolates reported in this study
sharing the same ST. The number on the connecting lines indicates the number of alleles that were different between the two connected nodes. In
addition, for the major serogroups (e.g. O157, O26) the STs and their corresponding clonal complexes (CC) were given and shaded in grey.
doi:10.1371/journal.pone.0073927.g002
Table 4. Phylogeny of EHEC isolated from HUS patients in the
Czech Republic determined by MLST.
Serotype
Total no.
of strains ST (no. of strains) CC




O157:NM (SF) 5 11 (5) 11
O55:NM 2 335 (2) 11
O26:H11/NM 16 21 (8) 29a (8) 29
29
O111:NM 6 16 (6) 29




O172:NM 1 660 n.a.
Orough:NM 2 660 (2) n.a.
ST, sequence type; CC, clonal complex; n.a., not assigned.
aST29 strains belong to the new EHEC O26 clone [7].
doi:10.1371/journal.pone.0073927.t004
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turn, from a low number of HUS cases that occur in this country
(4–5 per year).
SF EHEC O157:NM caused several HUS outbreaks through-
out Europe, the largest of which involved Germany [55,56],
Scotland [57] and Norway [58]. Such strains differ from O157:H7
phenotypically, in particular by their ability to ferment sorbitol
and produce b-D-glucuronidase, susceptibility to tellurite, lack of
EHEC hemolysin expression and non-motility [41,47], and by
expression of non-Stx toxins that may contribute to the
pathogenesis of EHEC-mediated diseases. Specifically, Cdt-V,
which causes irreversible injury to microvascular endothelial cells
[59], the major targets affected during HUS, is produced by the
majority of SF EHEC O157:NM strains [35], but only by a small
subset of EHEC O157:H7, which belong to particular phage types
[59]. Accordingly, all SF EHEC O157:NM and one NSF
O157:H7 strain analyzed in this study harbored the loci encoding
Cdt-V (Table 1). EHEC hemolysin, another toxin with a potential
endothelium-injuring capacity [60], was regularly expressed by
EHEC O157:H7, but not by SF O157:NM strains analyzed in this
study (Table 3). Several studies suggest that infections with SF
EHEC O157:NM more often progress to HUS [56–58] than those
with NSF O157 [61] and that patients infected with SF O157:NM
have a higher risk of death [56–58] than those infected with
EHEC O157:H7 [61]. In both German large outbreaks caused by
SF EHEC O157:NM strains the case-fatality ratio was 11%
[55,56] compared to ,1% reported for outbreaks caused by NSF
EHEC O157:H7 [61]. In agreement with the high virulence of SF
EHEC O157:NM strains, this strain was the cause of death in one
patient in our study. The other two fatal cases were associated with
infection by EHEC O26:H11, one of which belonged to the new
highly virulent clone, which has emerged in Europe [7] and
accounted for 50% of all O26 EHEC O26 isolated in this study.
EHEC O157:H7 have evolved from an E. coli O55:H7 ancestor
possessing the locus of enterocyte effacement (LEE) by acquisition
of Stx-encoding bacteriophages, virulence plasmid and transition
of somatic antigen from O55 to O157 [62–64]. Leopold et al. [63]
and others [65,66] provided evidence of limited diversity in SF
O157:NM, much unlike the large biodiversity of EHEC O157:H7.
We show that the NSF and SF O157 isolates described here all
belong to the same clonal complex (CC11); multilocus variable
number tandem repeat analysis (MLVA) and single nucleotide
polymorphism (SNP) analysis of the Czech strains is underway to
more extensively compare the phylogenetic relationships of these
strains and to compare them with strains from other countries
[63,67,68].
Tellurite resistance is a diagnostically important feature
enabling isolation of EHEC strains from CT-SMAC where
normal intestinal flora are suppressed. In our study tellurite
resistance occurred in all NSF EHEC O157, all O26 and both
O145 isolates and in five of six O111 strains. All these strains also
contained the ure cluster encoding urease production but none of
them produced urease, in accordance with observations that ure
genes are usually not expressed in EHEC strains [42]. The absence
of both ter and ure loci in one O111:NM strain (Table 1) suggest
that the strain have lost these loci, as have been previously
reported for EHEC O157:H7 and attributed to deletions within
OIs 43 and 48 that harbor these loci [69].
Antimicrobial susceptibility testing demonstrated resistance to
one (9 isolates) or two (1 isolate) antimicrobials in 25.6% of the
Czech EHEC strains studied. The resistance was associated with
non-O157 EHEC serogroups. This situation is similar to that in
Finland and Belgium where antimicrobial resistance was reported
in 21.4% and 44.7% of EHEC patients isolates, respectively, and it
was more frequent in non-O157 than in O157 strains [70,71]. As
in our study, none of the isolates from these countries was resistant
to meropenem or imipenem, ciprofloxacin and amikacin. In
contrast to our findings, multidrug resistance occurred in 24.1% of
the Belgian [71] and in 7.1% of the Finnish EHEC isolates [70], as
well as in an EHEC O145:H- strain that caused a multistate
outbreak of diarrhea and HUS in the United States [72]. The
extended-spectrum b-lactamase (ESBL) phenotype, which was
identified in an EHEC O26 human isolate in another Belgian
study [73], and which is one of the typical features of the EHEC
O104:H4 strain that caused the large 2011 outbreak in Germany
[53,74] was not tested in the Czech EHEC HUS isolates in this
study. Compared to EHEC, E. coli strains isolated from urine of
patients with urinary tract infections or from blood cultures of
patients with sepsis are more often multiresistant [75] or express
the ESBL phenotype [76,77].
The spectrum of EHEC serotypes associated with HUS in the
Czech Republic raises the question about reservoirs of these
pathogens and sources of human infections in this country.
Prevalence of EHEC in cattle feces in the Czech Republic was
investigated by Alexa et al. [78]. EHEC shedding was observed in
70% to 100% animals in three different diary farms. EHEC
isolates belonged to serogroups O26, O103, O157, O128, and
O54, the former three being isolated from HUS patients in our
study. Čı́žek et al. [79] studied the occurence of EHEC O157 in
diary farms in the Czech Republic. EHEC O157 strains harboring
stx1, stx2, eae, and EHEC-hlyA genes were detected in four of 192
in-line filters examined. Several additional studies identified
various animal species as sources of outbreaks or sporadic cases
of EHEC infections in this country. In 1995, four cases of HUS in
children caused by EHEC O157:H7 were associated with
consumption of unpasteurised milk from a farm goat who shed
the causative EHEC O157:H7 strain in its feces [80]. Three years
later, SF EHEC O157:NM strains were isolated from two siblings
(one with HUS and the other with diarrhea) and an epidemio-
logically associated cow, and a direct contact with the animal was
implicated as a possible infection transmission route [81]. This was
the first evidence that cattle can be a reservoir of SF EHEC O157
and a source of human diseases [81]. Altogether, these studies
demonstrate that similar to other countries [27,40,61], cattle and
other domestic animals are reservoires of EHEC in the Czech
Republic and can be sources of the infection for humans.
We conclude from our data that EHEC strains including
O157:H7/NM and a spectrum of non-O157 serotypes are
important causes of pediatric D+ HUS in the Czech Republic.
Although the spectrum of EHEC serotypes resembles that found in
other European countries, the finding of serotypes
O172:NM[fliCH25] and Orough:NM[fliCH25], which are not
members of the German HUSEC collection [3] (www.ehec.org)
indicates the need for creating an European collection of HUS-
associated EHEC. This collection would enable complex studies of
virulence characteristics, mechanisms of adaptation to the human
host and evolution of these pathogens, as well as development of
optimized methods for their detection.
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toxigenic Escherichia coli O157 and drug-resistant coliform bacteria from in-line
milk filters on dairy farms in the Czech Republic. J Appl Microbiol 104: 852–
860.
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